NPCE News and Press, Neuropace Inc. From 02/13/25

2025-02-13 16:48:27 ET Read the full article on Seeking Alpha For further details see: NeuroPace announces proposed public offering of $65M of common stock

MOUNTAIN VIEW, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) today announced that it intends to offer and sell, in an underwritten public offering, $65 million of shares of its common stock. All of the shares are being offered by NeuroPace. In addition, NeuroPace intend...

MOUNTAIN VIEW, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that an abstract featuring data from the Post-approval Study of the RNS System has been selected for ...

– 2025 revenue guidance of $92 million to $96 million – – 2025 gross margin guidance of 73% to 75% – – Three-year targets of 20% revenue CAGR and achievement of cash flow breakeven – MOUNTAIN VIEW, Calif., Jan. 28, 2025 (GL...

2025-01-22 11:44:48 ET More on iShares U.S. Medical Devices ETF: IHI: Multiples Have Climbed Despite Stubborn Rates Hedge funds were net buyers of financials, healthcare for week: Goldman Sachs Medtech shouldn't be greatly impacted by RFK Jr. at HHS, Wells Fargo says...

2025-01-08 16:14:33 ET More on Hyperfine, NeuroPace, etc. QuidelOrtho: Highly Levered With Questionable Growth NeuroPace, Inc. (NPCE) Q3 2024 Earnings Call Transcript Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript Jana Partners takes new stake in Lam...

Preliminary unaudited revenue expected to be between $21.0 million and $21.5 million for Q4 2024, and between $79.4 million and $79.9 million for full year 2024 Scott Huennekens Appointed to NeuroPace Board of Directors effective January 6 th ...

2025-01-06 05:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...